New US strategy to make monkeypox vaccine go further / Photo: Patrick T. FALLON - AFP
-
Wall Street stocks steady after positive jobs data
-
Trump blasts Democrats as government shutdown becomes longest ever
-
Indian pilgrims find 'warm welcome' in Pakistan despite tensions
-
Inter and AC Milan complete purchase of San Siro
-
Swedish authorities inspect worksite conditions at steel startup Stegra
-
Keys withdraws from WTA Finals with illness
-
Prince Harry says proud to be British despite new life in US
-
BMW boosts profitability, welcomes Nexperia signals
-
EU strikes last-ditch deal on climate targets as COP30 looms
-
Stocks retreat as tech bubble fears grow
-
Shein opens first permanent store amid heavy police presence
-
West Indies edge New Zealand despite Santner brilliance
-
French pair released by Iran await return home
-
German factory orders up but outlook still muted
-
Death toll tops 100 as Philippines digs out after typhoon
-
Attack on key city in Sudan's Kordofan region kills 40: UN
-
'No one could stop it': Sudanese describe mass rapes while fleeing El-Fasher
-
Champagne and cheers across New York as Mamdani soars to victory
-
Medieval tower collapse adds to Italy's workplace toll
-
BMW boosts profitability despite China, tariff woes
-
South Africa's Wiese wary of 'hurt' France before re-match
-
Asian markets sink as tech bubble fears grow
-
Beyond limits: Croatian freediver's breathtaking record
-
Tottenham supporting Udogie after alleged gun threat in London
-
Thunder roll Clippers to stay unbeaten as SGA keeps streak alive
-
In appeal, Australian mushroom murderer alleges 'miscarriage of justice'
-
Toyota hikes profit forecasts 'despite US tariffs'
-
Typhoon death toll soars past 90 in the Philippines
-
Ex-France lock Willemse challenges Meafou to become 'the bully'
-
Ukrainians to honour sporting dead by building country they 'died for': minister
-
At least 7 dead after UPS cargo plane crashes near Louisville airport
-
US Supreme Court hears challenge to Trump tariff powers
-
US government shutdown becomes longest in history
-
India's Modi readies bellwether poll in poorest state
-
Green goals versus growth needs: India's climate scorecard
-
Where things stand on China-US trade after Trump and Xi talk
-
Sri Lanka targets big fish in anti-corruption push
-
NY elects leftist mayor on big election night for Democrats
-
Injured Jordie Barrett to miss rest of All Blacks tour
-
Asian markets tumble as tech bubble fears grow
-
Pay to protect: Brazil pitches new forest fund at COP30
-
Australia pick 'impressive' Weatherald in first Ashes Test squad
-
Iraq's social media mercenaries dying for Russia
-
Young leftist Trump foe elected New York mayor
-
Concerns at ILO over expected appointment of close Trump advisor
-
Venus Williams to return to Auckland Classic at the age of 45
-
No deal yet on EU climate targets as COP30 looms
-
Typhoon death toll climbs to 66 in the Philippines
-
NATO tests war preparedness on eastern flank facing Russia
-
Uncapped opener Weatherald in Australia squad for first Ashes Test
New US strategy to make monkeypox vaccine go further
US health authorities on Tuesday authorized a new procedure for injecting the monkeypox vaccine that should make it possible to inoculate more people with the same amount of the drug, at a time when doses are running short in the country.
The Food and Drug Administration also authorized giving the vaccine to people under the age of 18 who are considered to be at high risk of infection.
For those over 18, health workers will now be able to administer the vaccine differently, via an intradermal injection -- that is, between the upper layers of the skin -- and not with a deeper, subcutaneous injection.
The new method will "increase the total number of doses available for use by up to five-fold," the FDA said in a statement.
Two injections, four weeks apart, will still be necessary.
The FDA said it was drawing on data from a 2015 clinical trial that showed a similar immune response in people given a subcutaneous injection compared to those given a fifth of the dose via an intradermal shot.
At present, some 620,000 doses of the vaccine -- manufactured by Bavarian Nordic, and marketed under the name Jynneos in the United States -- have been distributed across the country.
Another 440,000 additional doses are still to be distributed, which could allow up to 2.2 million injections under the new strategy.
The government has also ordered an additional five million doses, which will start arriving from September and run through 2023, affording the potential to administer 25 million doses.
The decisions came after the FDA issued an emergency use authorization for the vaccine, a move that itself followed the declaration of a public health emergency last week.
For the authorization in minors, the FDA said it had reviewed safety data for the vaccine, as well as data for another vaccine given in children against smallpox.
"We feel very comfortable with the safety of the approach," said Peter Marks of the FDA at a press conference, noting a recent increase in the number of children who have potentially been exposed to infected people.
The United States has registered nearly 9,000 cases of monkeypox, a fifth of them in New York state. The vast majority of cases involve men who have had sex with men.
P.AbuBaker--SF-PST
